CoChat

The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis

Savary, Grégoire, Dewaeles, Edmone, Diazzi, Serena, Buscot, Matthieu, Nottet, Nicolas, Fassy, Julien, Courcot, Elisabeth, Henaoui, Imène-Sarah, Lemaire, Julie, Martis, Nihal, Van der Hauwaert, Cynthia, Pons, Nicolas, Magnone, Virginie, Leroy, Sylvie, Hofman, Véronique, Plantier, Laurent, Lebrigand, Kevin, Paquet, Agnès, Lino Cardenas, Christian L., Vassaux, Georges, Hofman, Paul, Günther, Andreas, Crestani, Bruno, Wallaert, Benoit, Rezzonico, Roger, Brousseau, Thierry, Glowacki, François, Bellusci, Saverio, Perrais, Michael, Broly, Franck, Barbry, Pascal, Marquette, Charles-Hugo, Cauffiez, Christelle, Mari, Bernard, Pottier, Nicolas · 2019 · American Journal of Respiratory and Critical Care Medicine
Cited by 113

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Abstract Rationale Given the paucity of effective treatments for idiopathic pulmonary fibrosis (IPF), new insights into the deleterious mechanisms controlling lung fibroblast activation, the key cell type driving the fibrogenic process, are essential to develop new therapeutic strategies. TGF-β (transforming growth factor-β) is the main profibrotic factor, but its inhibition is associated with severe side effects because of its pleiotropic role. Objectives To determine if downstream noncoding effectors of TGF-β in fibroblasts may represent new effective therapeutic targets whose modulation may be well tolerated. Methods We investigated the whole noncoding fraction of TGF-β–stimulated lung fibroblast transcriptome to identify new genomic determinants of lung fibroblast differentiation into myofibroblasts. Differential expression of the long noncoding RNA (lncRNA) DNM3OS (dynamin 3 opposite strand) and its associated microRNAs (miRNAs) was validated in a murine model of pulmonary fibrosis and in IPF tissue samples. Distinct and complementary antisense oligonucleotide–based strategies aiming at interfering with DNM3OS were used to elucidate the role of DNM3OS and its associated miRNAs in IPF pathogenesis. Measurements and Main Results We identified DNM3OS as a fibroblast-specific critical downstream effector of TGF-β–induced lung myofibroblast activation. Mechanistically, DNM3OS regulates this process in trans by giving rise to three distinct profibrotic mature miRNAs (i.e., miR-199a-5p/3p and miR-214-3p), which influence SMAD and non-SMAD components of TGF-β signaling in a multifaceted way. In vivo, we showed that interfering with DNM3OS function not only prevents lung fibrosis but also improves established pulmonary fibrosis. Conclusions Pharmacological approaches aiming at interfering with the lncRNA DNM3OS may represent new effective therapeutic strategies in IPF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201807-1237oc

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 113

Metadata

Authors
Savary, G., Dewaeles, E., Diazzi, S., Buscot, M., Nottet, N., Fassy, J., Courcot, E., Henaoui, I.-S., Lemaire, J., Martis, N., Van der Hauwaert, C., Pons, N., Magnone, V., Leroy, S., Hofman, V., Plantier, L., Lebrigand, K., Paquet, A., Lino Cardenas, C. L., Vassaux, G., Hofman, P., Günther, A., Crestani, B., Wallaert, B., Rezzonico, R., Brousseau, T., Glowacki, F., Bellusci, S., Perrais, M., Broly, F., Barbry, P., Marquette, C.-H., Cauffiez, C., Mari, B., & Pottier, N.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2019-07-15
Volume
200
Issue
2
Pages
184-198
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2937142203
Cited by
113
References
16
FWCI
9.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.